rs181067717

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_001458.5(FLNC):​c.5578C>T​(p.Arg1860Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00811 in 1,614,026 control chromosomes in the GnomAD database, including 62 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1860H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0052 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0084 ( 60 hom. )

Consequence

FLNC
NM_001458.5 missense

Scores

2
7
10

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:17

Conservation

PhyloP100: 2.34
Variant links:
Genes affected
FLNC (HGNC:3756): (filamin C) This gene encodes one of three related filamin genes, specifically gamma filamin. These filamin proteins crosslink actin filaments into orthogonal networks in cortical cytoplasm and participate in the anchoring of membrane proteins for the actin cytoskeleton. Three functional domains exist in filamin: an N-terminal filamentous actin-binding domain, a C-terminal self-association domain, and a membrane glycoprotein-binding domain. Mutations in this gene are a cause of cardiopathy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2022]
FLNC-AS1 (HGNC:53474): (FLNC antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), FLNC. . Gene score misZ 2.789 (greater than the threshold 3.09). Trascript score misZ 5.9457 (greater than threshold 3.09). GenCC has associacion of gene with dilated cardiomyopathy, heart conduction disease, familial isolated restrictive cardiomyopathy, hypertrophic cardiomyopathy 26, distal myopathy with posterior leg and anterior hand involvement, myofibrillar myopathy 5.
BP4
Computational evidence support a benign effect (MetaRNN=0.0066719353).
BP6
Variant 7-128851270-C-T is Benign according to our data. Variant chr7-128851270-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 196888.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-128851270-C-T is described in Lovd as [Likely_benign]. Variant chr7-128851270-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00522 (795/152272) while in subpopulation AMR AF= 0.00961 (147/15298). AF 95% confidence interval is 0.00834. There are 2 homozygotes in gnomad4. There are 359 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 795 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
FLNCNM_001458.5 linkuse as main transcriptc.5578C>T p.Arg1860Cys missense_variant 34/48 ENST00000325888.13
FLNC-AS1NR_149055.1 linkuse as main transcriptn.315+131G>A intron_variant, non_coding_transcript_variant
FLNCNM_001127487.2 linkuse as main transcriptc.5479C>T p.Arg1827Cys missense_variant 33/47

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
FLNCENST00000325888.13 linkuse as main transcriptc.5578C>T p.Arg1860Cys missense_variant 34/481 NM_001458.5 P3Q14315-1
FLNCENST00000346177.6 linkuse as main transcriptc.5479C>T p.Arg1827Cys missense_variant 33/471 A1Q14315-2
FLNC-AS1ENST00000469965.1 linkuse as main transcriptn.315+131G>A intron_variant, non_coding_transcript_variant 4

Frequencies

GnomAD3 genomes
AF:
0.00522
AC:
794
AN:
152154
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00133
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00962
Gnomad ASJ
AF:
0.00605
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00806
Gnomad OTH
AF:
0.00526
GnomAD3 exomes
AF:
0.00536
AC:
1336
AN:
249482
Hom.:
9
AF XY:
0.00564
AC XY:
763
AN XY:
135374
show subpopulations
Gnomad AFR exome
AF:
0.000904
Gnomad AMR exome
AF:
0.00571
Gnomad ASJ exome
AF:
0.00725
Gnomad EAS exome
AF:
0.0000556
Gnomad SAS exome
AF:
0.00127
Gnomad FIN exome
AF:
0.00107
Gnomad NFE exome
AF:
0.00843
Gnomad OTH exome
AF:
0.00561
GnomAD4 exome
AF:
0.00842
AC:
12302
AN:
1461754
Hom.:
60
Cov.:
33
AF XY:
0.00815
AC XY:
5928
AN XY:
727184
show subpopulations
Gnomad4 AFR exome
AF:
0.00114
Gnomad4 AMR exome
AF:
0.00552
Gnomad4 ASJ exome
AF:
0.00742
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00152
Gnomad4 FIN exome
AF:
0.00154
Gnomad4 NFE exome
AF:
0.00999
Gnomad4 OTH exome
AF:
0.00790
GnomAD4 genome
AF:
0.00522
AC:
795
AN:
152272
Hom.:
2
Cov.:
33
AF XY:
0.00482
AC XY:
359
AN XY:
74464
show subpopulations
Gnomad4 AFR
AF:
0.00132
Gnomad4 AMR
AF:
0.00961
Gnomad4 ASJ
AF:
0.00605
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.000621
Gnomad4 FIN
AF:
0.000377
Gnomad4 NFE
AF:
0.00806
Gnomad4 OTH
AF:
0.00520
Alfa
AF:
0.00724
Hom.:
8
Bravo
AF:
0.00536
ESP6500AA
AF:
0.00124
AC:
5
ESP6500EA
AF:
0.00621
AC:
52
ExAC
AF:
0.00534
AC:
646
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00812
EpiControl
AF:
0.00812

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:17
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:7
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsNov 07, 2018- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 17, 2023- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2024FLNC: BS1, BS2 -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
not specified Benign:6
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJul 30, 2023- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Oct 27, 2014- -
Benign, criteria provided, single submitterclinical testingGeneDxFeb 29, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoMay 06, 2020- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Cardiomyopathy Benign:1
Benign, criteria provided, single submitterclinical testingCHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern OntarioJan 04, 2023- -
FLNC-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMay 09, 2019This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 17, 2023This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Myofibrillar myopathy 5;C3279722:Distal myopathy with posterior leg and anterior hand involvement;C4310749:Hypertrophic cardiomyopathy 26;CN239310:Dilated Cardiomyopathy, Dominant Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.33
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.53
D;.
Eigen
Uncertain
0.37
Eigen_PC
Uncertain
0.40
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Pathogenic
0.99
D;D
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.0067
T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
1.3
L;.
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.69
T
PROVEAN
Benign
-2.1
N;N
REVEL
Benign
0.21
Sift
Uncertain
0.0050
D;D
Sift4G
Uncertain
0.0070
D;D
Polyphen
0.96
D;D
Vest4
0.40
MVP
0.31
MPC
1.9
ClinPred
0.028
T
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.7
Varity_R
0.26
gMVP
0.75

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs181067717; hg19: chr7-128491324; API